Published December 16, 2020 | Version 1
Project deliverable Open

VALITEST - D2.2 "Best practice" guidelines for validation and routine use of non-targeted techniques in diagnostic setting which could serve as a basis for a new EPPO Standard

  • 1. ULg

Description

These guidelines provide recommendations on the process of selection, development, validation and verification of high-throughput sequencing (HTS) tests and the quality assurance for their routine use as diagnostic tests in plant health laboratories. These guidelines are general to enable a broad application in all plant health fields with appropriate flexibility to account for the changes of technologies.

The guidelines cover all steps from sample collection to reporting including risk analysis, test selection/test development, test validation/verification, quality checks to ensure the validity of the results, confirmation of the detection and interpretation of biological relevance within a quality management system. Furthermore, these guidelines provide an overview of the HTS technologies and their applications in plant health.

Files

VALITEST D2.2 Guidelines for validation and routine use of non-targeted techniques.pdf

Additional details

Funding

VALITEST – Validation of diagnostic tests to support plant health 773139
European Commission